Abstract
This study comprehensively explores the complexities of rheumatoid arthritis during pregnancy and its impact on offspring. Through an extensive review of existing literature, we investigate maternal and fetal risks, including adverse pregnancy outcomes and developmental issues in offspring. Utilizing reputable databases such as PubMed, Google Scholar, and Science Direct, we meticulously examined studies exploring the connection between rheumatoid arthritis and pregnancy complications, with a focus on outcomes for offspring. We excluded studies lacking sufficient data or peer review. Synthesizing findings from selected studies, we identified common themes and patterns, presenting results in a clear, organized manner. Our examination reveals a heightened likelihood of preterm birth and preeclampsia among pregnant individuals with rheumatoid arthritis, often correlated with disease activity. Furthermore, we highlight the impact on fetal and neonatal outcomes, such as low birth weight, underscoring the importance of meticulous disease management throughout pregnancy. Balancing the necessity of disease-modifying agents with potential risks, and consideration of medication safety is paramount. A multidisciplinary approach involving rheumatologists and obstetricians is crucial for optimizing outcomes. In conclusion, this synthesis underscores the nuanced challenges of rheumatoid arthritis in pregnancy. A comprehensive understanding and personalized, multidisciplinary approach to an organization is essential for informed decision-making in clinical practice. Our review contributes to ongoing discourse, providing insights for enhanced patient care and guiding future research endeavors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
Not applicable.
References
Al Rayes H, Abdulaziz S, Alotaibi AM, Alaithan MA, Attar M, Daghasi H, Melibari R, Althagafi AH, Elnady B (2021) Adverse impact of rheumatoid arthritis on pregnancy outcomes: a Saudi Arabia prospective multicenter study. Open Access Rheumatol Res Rev, 167–175
Anderka MT, Lin AE, Abuelo DN, Mitchell AA, Rasmussen SA (2009) Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature. Am J Med Genet A 149(6):1241–1248. https://doi.org/10.1002/ajmg.a.32685
Antonucci R, Zaffanello M, Puxeddu E, Porcella A, Cuzzolin L, Dolores Pilloni M, Fanos V (2012) Use of non-steroidal anti-inflammatory drugs in pregnancy: impact on the fetus and newborn. Curr Drug Metab 13(4):474–490. https://doi.org/10.2174/138920012800166607
Baerts W, Fetter WPF, Hop WCJ, Wallenburg HCS, Spritzer R, Sauer PJJ (1990) Cerebral lesions in preterm infants after tocolytic indomethacin. Dev Med Child Neurol 32(10):910–918. https://doi.org/10.1111/j.1469-8749.1990.tb08104.x
Banhidy F, Acs N, Puhó EH, Czeizel AE (2011) Chronic hypertension with related drug treatment of pregnant women and congenital abnormalities in their offspring: a population-based study. Hypertens Res 34(2):257–263. https://doi.org/10.1038/hr.2010.227
Barrett JH, Brennan P, Fiddler M, Silman AJ (1999) Does rheumatoid arthritis remit during pregnancy and relapse postpartum?: Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy. Arthritis Rheumatism 42(6):1219–1227. https://doi.org/10.1002/1529-0131(199906)42:6%3C1219::AID-ANR19%3E3.0.CO;2-G
Bharti B, Lee SJ, Lindsay SP, Wingard DL, Jones KL, Lemus H, Chambers CD (2015) Disease severity and pregnancy outcomes in women with rheumatoid arthritis: results from the organization of teratology information specialists autoimmune diseases in pregnancy project. J Rheumatol 42(8):1376–1382. https://doi.org/10.3899/jrheum.140583
Bizzaro N, Bartoloni E, Morozzi G, Manganelli S, Riccieri V, Sabatini P, Filippini M, Tampoia M, Afeltra A, Sebastiani G, Alpini C (2013) Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study. Arthritis Res Ther 15:1–9. https://doi.org/10.1186/ar4148
Borrero CG, Mountz JM, Mountz JD (2011) Emerging MRI methods in rheumatoid arthritis. Nat Rev Rheumatol 7(2):85–95. https://doi.org/10.1038/nrrheum.2010.173
Bowden AP, Barrett JH, Fallow WENDY, Silman AJ (2001) Women with inflammatory polyarthritis have babies of lower birth weight. J Rheumatol 28(2):355–359
Bröms G, Granath F, Ekbom A, Hellgren K, Pedersen L, Sørensen HT, Stephansson O, Kieler H (2016) Low risk of birth defects for infants whose mothers are treated with anti-Tumor Necrosis Factor agents during pregnancy. Clin Gastroenterol Hepatol 14(2):234–241. https://doi.org/10.1016/j.cgh.2015.08.039
Brouwer J, Laven JS, Hazes JM, Dolhain RJ (2015) Brief report: miscarriages in female rheumatoid arthritis patients: associations with serologic findings, disease activity, and antirheumatic drug treatment. Arthritis & Rheumatology 67(7):1738–1743. https://doi.org/10.1002/art.39137
Burmester GR, Dimitriu-Bona A, Waters SJ, Winchester RJ (1983) Identification of three major synovial lining cell populations by monoclonal antibodies directed to Ia antigens and antigens associated with monocytes/macrophages and fibroblasts. Scand J Immunol 17(1):69–82. https://doi.org/10.1111/j.1365-3083.1983.tb00767.x
Carmichael SL, Shaw GM (1999) Maternal corticosteroid use and risk of selected congenital anomalies. Am J Med Genet 86(3):242–244. https://doi.org/10.1002/(sici)1096-8628(19990917)86:3%3c242::aid-ajmg9%3e3.0.co;2-u
Carmichael SL, Shaw GM, Ma C, Werler MM, Rasmussen SA, Lammer EJ and Study NBDP (2007) Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol 197(6):585-e1. https://doi.org/10.1016/j.ajog.2007.05.046
Carter JD, Ladhani A, Ricca LR, Valeriano J, Vasey FB (2009) A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database. J Rheumatol 36(3):635–641. https://doi.org/10.3899/jrheum.080545
Cassina M, Johnson DL, Robinson LK, Braddock SR, Xu R, Jimenez JL, Mirrasoul N, Salas E, Luo YJ, Jones KL, Chambers CD (2012) Pregnancy outcome in women exposed to leflunomide before or during pregnancy. Arthritis Rheum 64(7):2085–2094. https://doi.org/10.1002/art.34419
Chakravarty EF (2011) Rheumatoid arthritis and pregnancy: beyond smaller and preterm babies. Arthritis Rheum 63(6):1469–1471. https://doi.org/10.1002/art.30206
Chakravarty EF, Nelson L, Krishnan E (2006) Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 54(3):899–907. https://doi.org/10.1002/art.21663
Chakravarty EF, Murray ER, Kelman A, Farmer P (2011) Pregnancy outcomes after maternal exposure to rituximab. Blood J Am Soc Hematol 117(5):1499–1506. https://doi.org/10.1182/blood-2010-07-295444
Chang Z, Spong CY, Jesus AA, Davis MA, Plass N, Stone DL, Chapelle D, Hoffmann P, Kastner DL, Barron K and Goldbach‐Mansky RT (2014) Brief report: anakinra use during pregnancy in patients with cryopyrin‐associated periodic syndromes.https://doi.org/10.1002/art.38811
Cleary BJ, Källén B (2009) Early pregnancy azathioprine use and pregnancy outcomes. Birth Defects Res A 85(7):647–654. https://doi.org/10.1002/bdra.20583
Costedoat-Chalumeau N, Amoura Z, Aymard G, Du Le Thi Hong, DLTH, Wechsler B, Vauthier D, Dermer ME, Darbois Y, Piette JC (2002) Evidence of transplacental passage of hydroxychloroquine in humans
Dawood MY (1993) Non-steroidal anti-inflammatory drugs and reproduction. Am J Obstet Gynecol 169:1255–1265. https://doi.org/10.1002/art.10150
Dawson AL, Riehle-Colarusso T, Reefhuis J, Arena JF, National Birth Defects Prevention Study (2014) Maternal exposure to methotrexate and birth defects: a population-based study. Am J Med Genet A 164(9):2212–2216. https://doi.org/10.1002/ajmg.a.36625
De Man YA, Dolhain RJ, Van De Geijn FE, Willemsen SP, Hazes JM (2008) Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Care Res 59(9):1241–1248. https://doi.org/10.1002/art.24003
De Man YA, Bakker-Jonges LE, Dufour-Van Den Goorbergh CM, Tillemans SPR, Hooijkaas H, Hazes JMW, Dolhain RJEM (2010) Women with rheumatoid arthritis negative for anti-cyclic citrullinated peptide and rheumatoid factor are more likely to improve during pregnancy, whereas in autoantibody-positive women autoantibody levels are not influenced by pregnancy. Ann Rheum Dis 69(2):420–423
de Man YA, Hazes JM, van der Heide H, Willemsen SP, de Groot CJ, Steegers EA, Dolhain RJ (2009) Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study. Arthritis Rheumatism 60(11):3196–3206. https://doi.org/10.1002/art.24914
de Steenwinkel FD, Hokken-Koelega AC, de Man YA, de Rijke YB, de Ridder MA, Hazes JM, Dolhain RJ (2013) Circulating maternal cytokines influence fetal growth in pregnant women with rheumatoid arthritis. Ann Rheum Dis 72(12):1995–2001
de Steenwinkel FD, Hokken-Koelega AC, de Ridder MA, Hazes JM, Dolhain RJ (2014a) Rheumatoid arthritis during pregnancy and postnatal catch-up growth in the offspring. Arthritis Rheumatol 66(7):1705–1711. https://doi.org/10.1002/art.38519
de Steenwinkel FD, Hokken-Koelega AC, Hazes JM, Dolhain RJ (2014b) The influence of foetal prednisone exposure on the cortisol levels in the offspring. Clin Endocrinol 80(6):804–810. https://doi.org/10.1111/cen.12388
Dedmon LE (2020) The genetics of rheumatoid arthritis. Rheumatology 59(10):2661–2670. https://doi.org/10.1093/rheumatology/keaa232
Diav-Citrin O, Shechtman S, Schwartz V, Avgil-Tsadok M, Finkel-Pekarsky V, Wajnberg R, Arnon J, Berkovitch M, Ornoy A (2010) Pregnancy outcome after in utero exposure to colchicine. Am J Obstet Gynecol 203(2):144-e1. https://doi.org/10.1016/j.ajog.2010.02.063
Diav-Citrin O, Blyakhman S, Shechtman S, Ornoy A (2013) Pregnancy outcome following in utero exposure to hydroxychloroquine: a prospective comparative observational study. Reprod Toxicol 39:58–62. https://doi.org/10.1016/j.reprotox.2013.04.005
Erez O, Mastrolia SA, Thachil J (2015) Disseminated intravascular coagulation in pregnancy: insights in pathophysiology, diagnosis and management. Am J Obstet Gynecol 213(4):452–463. https://doi.org/10.1016/j.ajog.2015.03.054
Filer A, Parsonage G, Smith E, Osborne C, Thomas AM, Curnow SJ, Rainger GE, Raza K, Nash GB, Lord J, Salmon M (2006) Differential survival of leukocyte subsets mediated by synovial, bone marrow, and skin fibroblasts: site-specific versus activation-dependent survival of T cells and neutrophils. Arthritis Rheumatism 54(7):2096–2108. https://doi.org/10.1002/art.21930
Flint J, Panchal S, Hurrell A, van de Venne M, Gayed M, Schreiber K, Arthanari S, Cunningham J, Flanders L, Moore L, Crossley A (2016) BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Rheumatology 55(9):1693–1697. https://doi.org/10.1093/rheumatology/kev404
Förger F, Vallbracht I, Helmke K, Villiger PM, Ostensen M (2012) Pregnancy mediated improvement of rheumatoid arthritis. Swiss Med Wkly 142(2930):w13644–w13644. https://doi.org/10.4414/smw.2012.13644
Fukui S, Iwamoto N, Horai Y, Ichinose K, Kosai K (2018) M1 and M2 monocytes in rheumatoid arthritis: a contribution of imbalance of M1/M2 monocytes to osteoclastogenesis. Front Immunol 8:307698. https://doi.org/10.3389/fimmu.2017.01958
Fukushima R, Kanamori S, Hirashiba M, Hishikawa A, Muranaka RI, Kaneto M, Nakamura K, Kato I (2007) Teratogenicity study of the dihydroorotate-dehydrogenase inhibitor and protein tyrosine kinase inhibitor Leflunomide in mice. Reprod Toxicol 24(3–4):310–316. https://doi.org/10.1016/j.reprotox.2007.05.006
Gabriel SE (2001) The epidemiology of rheumatoid arthritis. Rheumatic Disease Clinics of North America 27(2):269–281. https://doi.org/10.1016/S0889-857X(05)70201-5
Gerosa M, Schioppo T, Meroni PL (2016) Challenges and treatment options for rheumatoid arthritis during pregnancy. Expert Opin Pharmacother 17(11):1539–1547. https://doi.org/10.1080/14656566.2016.1197204
Golding A, Haque UJ, Giles JT (2007) Rheumatoid arthritis and reproduction. Rheumatic Disease Clinics of North America 33(2):319–343. https://doi.org/10.1016/j.rdc.2007.01.001
Guller S, Kong L, Wozniak ROBERT, Lockwood CJ (1995) Reduction of extracellular matrix protein expression in human amnion epithelial cells by glucocorticoids: a potential role in preterm rupture of the fetal membranes. J Clin Endocrinol Metab 80(7):2244–2250. https://doi.org/10.1210/jcem.80.7.7608287
Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J (2018) Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Research 6(1):15. https://doi.org/10.1038/s41413-018-0016-9
Harre U, Georgess D, Bang H, Bozec A, Axmann R, Ossipova E, Jakobsson PJ, Baum W, Nimmerjahn F, Szarka E, Sarmay G (2012) Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Investig 122(5):1791–1802. https://doi.org/10.1172/JCI60975
Hickok DE, Hollenbach KA, Reilley SF, Nyberg DA (1989) The association between decreased amniotic fluid volume and treatment with nonsteroidal anti-inflammatory agents for preterm labor. Am J Obstet Gynecol 160(6):1525–1531. https://doi.org/10.1016/0002-9378(89)90880-6
Hoeltzenbein M, Elefant E, Vial T, Finkel-Pekarsky V, Stephens S, Clementi M, Allignol A, Weber-Schoendorfer C, Schaefer C (2012) Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services. Am J Med Genet A 158(3):588–596. https://doi.org/10.1002/ajmg.a.35223
Hueber AJ, Asquith DL, Miller AM, Reilly J, Kerr S, Leipe J, Melendez AJ, McInnes IB (2010) Cutting edge: mast cells express IL-17A in rheumatoid arthritis synovium. J Immunol 184(7):3336–3340. https://doi.org/10.4049/jimmunol.0903566
Hviid A, Mølgaard-Nielsen D (2011) Corticosteroid use during pregnancy and risk of orofacial clefts. CMAJ 183(7):796–804. https://doi.org/10.1503/cmaj.101063
In Je K, Hyoun-Ah K, Chang-Hee S, Yong-Wook P, Hye-Soon L, So-Young B, Sang-Cheol B, Young Mo K, Won Kyung L, Hyesook P, Jisoo L (2012) Childbearing decisions and family size among women with systemic lupus erythematosus. Rheumatology 51. https://doi.org/10.1002/art.21859
Jethwa H, Lam S, Smith C, Giles I (2019) Does rheumatoid arthritis really improve during pregnancy? A systematic review and metaanalysis. J Rheumatol 46(3):245–250. https://doi.org/10.3899/jrheum.180226
Katz PP (2006) Childbearing decisions and family size among women with rheumatoid arthritis. Arthritis Rheum 55(2):217–223. https://doi.org/10.1002/art.21859
Klareskog L, Rönnelid J, Saevarsdottir S, Padyukov L, Alfredsson L (2020) The importance of differences; On environment and its interactions with genes and immunity in the causation of rheumatoid arthritis. J Intern Med 287(5):514–533. https://doi.org/10.1111/joim.13058
Kłodziński Ł, Wisłowska M (2018) Współchorobowość w Reumatoidalnym Zapaleniu Stawów. Reumatologia 56(4):228–233. https://doi.org/10.5114/reum.2018.77974
Kraaimaat FW, Bakker AH, Janssen E, Bijlsma JW (1996) Intrusiveness of rheumatoid arthritis on sexuality in male and female patients living with a spouse. Arthritis Rheumatism 9(2):120–125. https://doi.org/10.1002/1529-0131(199604)9:2%3C120::AID-ANR1790090208%3E3.0.CO;2-T
Krause ML, Makol A (2016) Management of rheumatoid arthritis during pregnancy: challenges and solutions. Open Access Rheumatol Res Rev pp 23–36
Krishnamurthy A, Joshua V, Hensvold AH, Jin T, Sun M, Vivar N, Ytterberg AJ, Engström M, Fernandes-Cerqueira C, Amara K, Magnusson M (2016) Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss. Ann Rheum Dis 75(4):721–729
Langen ES, Chakravarty EF, Liaquat M, El-Sayed YY, Druzin ML (2013) High rate of preterm birth in pregnancies complicated by rheumatoid arthritis. Am J Perinatol. https://doi.org/10.1055/s-0032-1326983
Lee SK, Aziz K, Dunn M, Clarke M, Kovacs L, Ojah C, Xiang YY and Canadian Neonatal Network (2012) Transport Risk Index of Physiologic Stability, version II (TRIPS-II): a simple and practical neonatal illness severity score. Am J Perinatol pp 395–400. https://doi.org/10.1055/s-0032-1326983
Leunissen RW, Kerkhof GF, Stijnen T, Hokken-Koelega A (2009) Timing and tempo of first-year rapid growth in relation to cardiovascular and metabolic risk profile in early adulthood. JAMA 301(21):2234–2242. https://doi.org/10.1001/jama.2009.761
Li DK, Liu L, Odouli R (2003) Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ 327(7411):368. https://doi.org/10.1136/bmj.327.7411.368
Manchester D, Margolis HS, Sheldon RE (1976) Possible association between maternal indomethacin therapy and primary pulmonary hypertension of the newborn. Am J Obstet Gynecol 126(4):467–469. https://doi.org/10.1016/0002-9378(76)90640-2
McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365(23):2205–2219. https://doi.org/10.1056/NEJMra1004965
Michael O, Goldman RD, Koren G and Team M (2003) Safety of colchicine therapy during pregnancy. Can Fam Physician 49(8):967–969
Moorthie S, Blencowe H, Darlison MW, Lawn J, Morris JK, Modell B, Congenital Disorders Expert Group, Bittles AH, Blencowe H, Christianson A, Cousens S (2018) Estimating the birth prevalence and pregnancy outcomes of congenital malformations worldwide. J Community Genet 9:387–396. https://doi.org/10.1007/s12687-018-0384-2
Murata Y, Itakura A, Matsuzawa K, Okumura A, Wakai K, Mizutani S (2005) Possible antenatal and perinatal related factors in development of cystic periventricular leukomalacia. Brain Develop 27(1):17–21. https://doi.org/10.1016/j.braindev.2004.02.011
Musiej-Nowakowska E, Ploski R (1999) Pregnancy and early onset pauciarticular juvenile chronic arthritis. Ann Rheum Dis 58(8):475–480
Nelson JL, Østensen M (1997) Pregnancy and rheumatoid arthritis. Rheumatic Disease Clinics of North America 23(1):195–212. https://doi.org/10.1016/S0889-857X(05)70323-9
Ngeh N, Bhide A (2006) Antepartum haemorrhage. Curr Obstet Gynaecol 16(2):79–83. https://doi.org/10.1016/j.curobgyn.2006.01.003
Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, Saigo K, Morinobu A, Koshiba M, Kuntz KM, Kamae I (2007) Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 146(11):797–808. https://doi.org/10.7326/0003-4819-146-11-200706050-00008
Nørgaard M, Larsson H, Pedersen L, Granath F, Askling J, Kieler H, Ekbom A, Sørensen HT, Stephansson O (2010) Rheumatoid arthritis and birth outcomes: a Danish and Swedish nationwide prevalence study. J Intern Med 268(4):329–337. https://doi.org/10.1111/j.1365-2796.2010.02239.x
Nørgård B, Pedersen L, Fonager K, Rasmussen SN, Sørensen HT (2003) Azathioprine, mercaptopurine and birth outcome: a population-based cohort study. Aliment Pharmacol Ther 17(6):827–834. https://doi.org/10.1046/j.1365-2036.2003.01537.x
Nurmohamed L, Moretti ME, Schechter T, Einarson A, Johnson D, Lavigne SV, Erebara A, Koren G, Finkelstein Y (2011) Outcome following high-dose methotrexate in pregnancies misdiagnosed as ectopic. Am J Obstet Gynecol 205(6):533-e1. https://doi.org/10.1016/j.ajog.2011.07.002
Oka M (1953) Effect of pregnancy on the onset and course of rheumatoid arthritis. Ann Rheumatic Diseases 12(3):227. https://doi.org/10.1136/ard.12.3.227
Okamoto K, Nakashima T, Shinohara M, Negishi-Koga T, Komatsu N, Terashima A, Sawa S, Nitta T, Takayanagi H (2017) Osteoimmunology: the conceptual framework unifying the immune and skeletal systems. Physiol Rev 97(4):1295–1349. https://doi.org/10.1152/physrev.00036.2016
Ong KK, Dunger DB (2002) Perinatal growth failure: the road to obesity, insulin resistance and cardiovascular disease in adults. Best Pract Res Clin Endocrinol Metab 16(2):191–207. https://doi.org/10.1053/beem.2002.0195
Østensen M, Khamashta M, Lockshin M, Parke A, Brucato A, Carp H, Doria A, Rai R, Meroni P, Cetin I, Derksen R (2006) Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 8:1–19. https://doi.org/10.1186/ar1957
Østensen M, Andreoli L, Brucato A, Cetin I, Chambers C, Clowse ME, Costedoat-Chalumeau N, Cutolo M, Dolhain R, Fenstad MH, Förger F (2015) State of the art: reproduction and pregnancy in rheumatic diseases. Autoimmun Rev 14(5):376–386. https://doi.org/10.1016/j.autrev.2014.12.011
Park-Wyllie L, Mazzotta P, Pastuszak A, Moretti ME, Beique L, Hunnisett L, Friesen MH, Jacobson S, Kasapinovic S, Chang D, Diav-Citrin O (2000) Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 62(6):385–392. https://doi.org/10.1002/1096-9926(200012)62:6%3C385::AID-TERA5%3E3.0.CO;2-Z
Pendergraft WF, McGrath MM, Murphy AP, Murphy P, Laliberte KA, Greene MF, Niles JL (2013) Fetal outcomes after rituximab exposure in women with autoimmune vasculitis. Ann Rheum Dis 72(12):2051–2053. https://doi.org/10.1136/annrheumdis-2013-203833
Piggott KD, Sorbello A, Riddle E, DeCampli W (2011) Congenital cardiac defects: a possible association of aminopterin syndrome and in utero methotrexate exposure? Pediatr Cardiol 32(4):518–520. https://doi.org/10.1007/s00246-011-9913-z
Pinsky L, DiGeorge AM (1965) Cleft palate in the mouse: a teratogenic index of glucocorticoid potency. Science 147(3656):402–403. https://doi.org/10.1126/science.147.3656.402
Poggi SH, Ghidini A (2011) Importance of timing of gestational exposure to methotrexate for its teratogenic effects when used in setting of misdiagnosis of ectopic pregnancy. Fertil Steril 96(3):669–671. https://doi.org/10.1016/j.fertnstert.2011.06.014
Rabinovitch O, Zemer D, Kukia E, Sohar E, Mashiach S (1992) Colchicine treatment in conception and pregnancy: two hundred thirty-one pregnancies in patients with familial Mediterranean fever. Am J Reprod Immunol 28(3–4):245–246. https://doi.org/10.1111/j.1600-0897.1992.tb00805.x
Rattray DD, O’Connell CM, Baskett TF (2012) Acute disseminated intravascular coagulation in obstetrics: a tertiary centre population review (1980 to 2009). J Obstet Gynaecol Can 34(4):341–347. https://doi.org/10.1016/S1701-2163(16)35214-8
Reed SD, Vollan TA, Svec MA (2006) Pregnancy outcomes in women with rheumatoid arthritis in Washington State. Matern Child Health J 10:361–366
Reinisch JM, Simon NG, Gandelman R (1980) Prenatal exposure to prednisone permanently alters fighting behavior of female mice. Pharmacol Biochem Behav 12(2):213–216. https://doi.org/10.1016/0091-3057(80)90358-5
Rumack CM, Guggenheim MA, Rumack BH, Peterson RG, Johnson ML, Braithwaite WR (1981) Neonatal intracranial hemorrhage and maternal use of aspirin. Obstet Gynecol 58(5):52S-56S
Sabeh F, Fox D, Weiss SJ (2010) Membrane-type I matrix metalloproteinase-dependent regulation of rheumatoid arthritis synoviocyte function. J Immunol 184(11):6396–6406. https://doi.org/10.4049/jimmunol.0904068
Sangle SR, Lutalo PM, Davies RJ, Khamashta MA, D’Cruz DP (2013) B-cell depletion therapy and pregnancy outcome in severe, refractory systemic autoimmune diseases. J Autoimmun 43:55–59. https://doi.org/10.1016/j.jaut.2013.03.001
Sharma UR, Nediyedath Rathnakaran A, Raj BP, Padinjakkara G, Das A, Vada S, Mudagal MP (2021) The positive effect of pregnancy in rheumatoid arthritis and the use of medications for the management of rheumatoid arthritis during pregnancy. Inflammopharmacology 29:987–1000
Siebert S, Tsoukas A, Robertson J, McInnes I (2015) Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases. Pharmacol Rev 67(2):280–309
Silman AJ, Hochberg MC (1993) Epidemiology of the rheumatic diseases. Oxford University Press
Silman AJ, Pearson JE (2002) Epidemiology and genetics of rheumatoid arthritis. Arthritis Res Ther 4:1–8. https://doi.org/10.1186/ar578
Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, Moreland LW, O’Dell J, Winthrop KL, Beukelman T, Bridges SL Jr (2012) 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res 64(5):625–639
Skomsvoll JF, Østensen M, Irgens LM, Baste V (1998) Obstetrical and neonatal outcome in pregnant patients with rheumatic disease. Scand J Rheumatol 27(sup107):109–112. https://doi.org/10.1080/03009742.1998.11720781
Skorpen CG, Hoeltzenbein M, Tincani A, Fischer-Betz R, Elefant E, Chambers C, Da Silva J, Nelson-Piercy C, Cetin I, Costedoat-Chalumeau N, Dolhain R (2016) The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 75(5):795–810
Smeele HTW, Dolhain RJEM (2019, December) Current perspectives on fertility, pregnancy and childbirth in patients with rheumatoid arthritis. In Seminars in arthritis and rheumatism (Vol. 49, No. 3, pp S32–S35). WB Saunders. https://doi.org/10.1016/j.semarthrit.2019.09.010
Smolen JS, Landewé R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, Gorter S, Knevel R, Nam J, Schoels M, Aletaha D (2010) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 69(6):964–975. https://doi.org/10.1136/ard.2009.126532
Soh MC, Nelson-Piercy C (2015) High-risk pregnancy and the rheumatologist. Rheumatology 54(4):572–587
Suurmond J, Rivellese F, Dorjée AL, Bakker AM, Rombouts YJ, Rispens T, Wolbink G, Zaldumbide A, Hoeben RC, Huizinga TW, Toes RE (2015) Toll-like receptor triggering augments activation of human mast cells by anti-citrullinated protein antibodies. Ann Rheum Dis 74(10):1915–1923. https://doi.org/10.1136/annrheumdis-2014-205562
Symmons DPM, Barrett EM, Bankhead CR, Scott DGL, Silman AJ (1994) The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Rheumatology 33(8):735–739. https://doi.org/10.1093/rheumatology/33.8.735
Tsai YC, Chang HC, Chiou MJ, Luo SF, Kuo CF (2022) Fetal–neonatal and maternal pregnancy outcomes in women with rheumatoid arthritis: a population-based cohort study. BMJ Open 12(10):e059203
Van der Weiden RM, Wouters JM (1997) Infertility may sometimes be associated with non-steroidal anti-inflammatory drug consumption. Br J Rheumatol 36(5):605–605. https://doi.org/10.1093/rheumatology/36.5.605a
Van Marter LJ, Leviton A, Allred EN, Pagano M, Sullivan KF, Cohen A, Epstein MF (1996) Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy. Pediatrics 97(5):658–663. https://doi.org/10.1542/peds.97.5.658
Wallenius M, Salvesen KÅ, Daltveit AK, Skomsvoll JF (2014) Rheumatoid arthritis and outcomes in first and subsequent births based on data from a national birth registry. Acta Obstet Gynecol Scand 93(3):302–307. https://doi.org/10.1111/aogs.12324
Weyand CM, Hicok KC, Conn DL, Goronzy JJ (1992) The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 117(10):801–806. https://doi.org/10.7326/0003-4819-117-10-801
Wigerblad G, Bas DB, Fernades-Cerqueira C, Krishnamurthy A, Nandakumar KS, Rogoz K, Kato J, Sandor K, Su J, Jimenez-Andrade JM, Finn A (2016) Autoantibodies to citrullinated proteins may induce joint pain independent of inflammation. Ann Rheum Dis 75(4):730–738. https://doi.org/10.1136/annrheumdis-2015-208094
Wolfberg AJ, Lee-Parritz A, Peller AJ, Lieberman ES (2004) Association of rheumatologic disease with preeclampsia. Obstet Gynecol 104(5 Part 1), 1106. https://doi.org/10.1097/01.AOG.0000145742.80937.6d
Acknowledgements
We are thankful to the chairman, management, principal, teaching and non-teaching staff of Acharya & BM Reddy College of Pharmacy, Bengaluru for providing us with necessary support throughout our review submission.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Rohini, S., Sharma, U.R., Vinutha, M. et al. Rheumatoid arthritis-associated complications during pregnancy and its effect on offspring: comprehensive review. Inflammopharmacol (2024). https://doi.org/10.1007/s10787-024-01482-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10787-024-01482-3